Article

Unlocking glioblastoma vulnerabilities with CRISPR-based genetic screening

2024-04-10

Abstract excerpt

Glioblastoma (GBM) is the most common malignant brain tumor in adults. Despite advancements in treatment, the prognosis for patients with GBM remains poor due to its aggressive nature and resistance to therapy. CRISPR-based genetic screening has emerged as a powerful tool for identifying genes crucial for tumor progression and treatment resistance, offering promising targets for tumor therapy. In this review, we p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c9fb9e22-f9d4-532f-94e3-e372bf24c3a1
DOI: 10.20944/preprints202404.0711.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Unlocking glioblastoma vulnerabilities with CRISPR-based genetic screeningDOI 10.20944/preprints202404.0711.v1Read

Unlocking Glioblastoma Vulnerabilities with CRISPR-Based Genetic ScreeningSemantic proximity Read

Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme.Semantic proximity Read

Genome scale CRISPR Cas9a knockout screen reveals genes that controls glioblastoma susceptibility to the alkylating agent temozolomideSemantic proximity Read

Progresses, Challenges, and Prospects of CRISPR/Cas9 Gene-Editing in Glioma StudiesSemantic proximity Read

Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR LibrariesSemantic proximity Read

CRISPR-Cas9 Screen Reveals PSMB3 Contributes to Gliomagenesis Through Proteasome-Dependent and Independent MechanismsSemantic proximity Read

AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma.Semantic proximity Read

Glioblastoma: new therapeutic strategies to address cellular and genomic complexitySemantic proximity Read

Fitness Screens Map State-Specific Glioblastoma Stem Cell VulnerabilitiesSemantic proximity Read

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy.Semantic proximity Read

Targeting the non-coding genome and temozolomide signature enables CRISPR-mediated glioma oncolysisSemantic proximity Read

Precision Oncology in the CRISPR Era: Applications and Future Horizons in Cancer TherapySemantic proximity Read